A
Alexei Yavlinsky
Researcher at University College London
Publications - 45
Citations - 825
Alexei Yavlinsky is an academic researcher from University College London. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 12, co-authored 28 publications receiving 592 citations. Previous affiliations of Alexei Yavlinsky include Imperial College London.
Papers
More filters
Book ChapterDOI
Automated image annotation using global features and robust nonparametric density estimation
TL;DR: It is shown that under this framework quite simple image properties such as global colour and texture distributions provide a strong basis for reliably annotating images.
Journal ArticleDOI
Is Africa prepared for tackling the COVID-19 (SARS-CoV-2) epidemic. Lessons from past outbreaks, ongoing pan-African public health efforts, and implications for the future
Nathan Kapata,Chikwe Ihekweazu,Francine Ntoumi,Francine Ntoumi,Tajudeen Raji,Pascalina Chanda-Kapata,Peter Mwaba,Victor Mukonka,Matthew Bates,John Tembo,Victor M. Corman,Sayoki Mfinanga,Danny Asogun,Linzy Elton,Liã Bárbara Arruda,Margaret J. Thomason,Leonard E. G. Mboera,Alexei Yavlinsky,Najmul Haider,David Simons,Lara Hollmann,Swaib A. Lule,Francisco Veas,Muzamil Mahdi Abdel Hamid,Osman Dar,Sarah Edwards,Francesco Vairo,Timothy D. McHugh,Christian Drosten,Richard Kock,Giuseppe Ippolito,Alimuddin Zumla +31 more
TL;DR: Nathan Kapata, Chikwe Ihekweazu, Francine Ntoumi, Tajudeen Raji, Pascalina Chanda-Kapata, Peter Mwaba, Victor Mukonka, Matthew Bates, John Tembo, Victor Corman, Sayoki Mfinanga, Danny Asogun, Linzy Elton, Liã Bárbara Arruda, Margaret J Thomason, Leonard Mboera, Alexei Yavlinsky
Journal ArticleDOI
Passengers' destinations from China: low risk of Novel Coronavirus (2019-nCoV) transmission into Africa and South America.
Najmul Haider,Alexei Yavlinsky,David Simons,Abdinasir Yusuf Osman,Francine Ntoumi,Alimuddin Zumla,Richard Kock +6 more
TL;DR: The risk of transmission of 2019-nCoV through human passenger air flight from four major cities of China to the passengers' destination countries was very high in neighbouring Asian countries, followed by Europe (UK, France, Russia and Germany), Oceania (Australia) and North America (USA and Canada).
Journal ArticleDOI
The Global Health Security index and Joint External Evaluation score for health preparedness are not correlated with countries' COVID-19 detection response time and mortality outcome.
Najmul Haider,Alexei Yavlinsky,Yu-Mei Chang,Mohammad Hasan,Camilla T. O. Benfield,Abdinasir Yusuf Osman,Md. Jamal Uddin,Osman Dar,Francine Ntoumi,Alimuddin Zumla,Richard Kock +10 more
TL;DR: In this paper, the authors evaluated the effectiveness of Global Health Security Index (GHSI) and Joint External Evaluation (JEE) in predicting countries' COVID-19 detection response times and mortality outcome (deaths/million) and used two different outcomes for the evaluation: (i) detection response time, the duration of time to the first confirmed case detection (from 31st December 2019 to 20th February 2020 when every country's first case was linked to travel from China) until 11th March and 1st July 2020, respectively.
Journal ArticleDOI
Discovery and validation of a personalized risk predictor for incident tuberculosis in low transmission settings.
Rishi K Gupta,Claire J. Calderwood,Alexei Yavlinsky,Maria Krutikov,Matteo Quartagno,Maximilian C. Aichelburg,Neus Altet,Roland Diel,Claudia C. Dobler,Claudia C. Dobler,José Domínguez,Joseph Doyle,Joseph Doyle,Connie Erkens,Steffen Geis,Pranabashis Haldar,Anja M. Hauri,Thomas Stig Hermansen,James C. Johnston,Christoph Lange,Berit Lange,Frank van Leth,Laura Muñoz,Christine Roder,Christine Roder,Kamila Romanowski,David Roth,Martina Sester,Rosa Sloot,Giovanni Sotgiu,Gerrit Woltmann,Takashi Yoshiyama,Jean-Pierre Zellweger,Dominik Zenner,Robert W Aldridge,Andrew Copas,Molebogeng X Rangaka,Marc Lipman,Marc Lipman,Mahdad Noursadeghi,Ibrahim Abubakar +40 more
TL;DR: A personalized risk predictor was developed to better target preventative treatment to individuals at greatest risk, supporting evidence-based clinical decision-making for latent TB.